HexagonFab secures £1.9m (USD 2.6m) seed funding to launch the Bolt, an analytical lab instrument to speed discovery and production of next-generation biopharmaceuticals The Bolt provides convenient and affordable access to molecular binding analytics Cambridge/Zurich – University of Cambridge spin-out company HexagonFab today announces a £1.9 million (USD 2.6 million) seed funding round, led by Cambridge […]
New service reduces project time from months to weeks for biopharma customers SOUTH SAN FRANCISCO — Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced the launch of its Pharma Assay Development (PAD) services to accelerate biomarker discovery and cell and gene therapy development pipelines for biopharma customers. The PAD Team […]
Expanded facility: New 7,500-square-foot Customer Interaction Center in Beijing, China Dedicated space for demonstration and factory acceptance testing of equipment Beijing, China — Sartorius, a leading international partner of life science research and the biopharmaceutical industry, is expanding its presence in China by opening a new Customer Interaction Center (CIC), located in the Shunyi District, […]
BURLINGAME, Calif. — Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has launched its latest product, called the Aura CL. Until now, there has been no effective way to measure subvisible particles in cellular therapeutics. The Aura CL is the next generation in Halo Labs’ popular family of instruments. […]
MARLBOROUGH, Mass. — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the closing of its initial public offering of 7,567,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase 987,000 additional shares of common stock, at the initial public offering price of […]
SAN DIEGO, Calif. — Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the appointments of Jeff Journey as Chief Commercial Officer, David Melaugh as General Counsel, and Jeff Labbadia as VP of Operations. “We are thrilled to welcome Jeff, David, and Jeff to the Element team,” said Molly He, Ph.D., […]
CHARLOTTESVILLE, Va.– LumaCyte, a leader in advanced label-free single-cell analytics through its novel Laser Force Cytology™ (LFC™) platform, announces today the addition of Jim Robinson to its Scientific Advisory Board (SAB). Jim brings more than 35 years of CMC vaccine manufacturing experience to the LumaCyte SAB, holding previous executive level positions at Merck, Sanofi Pasteur and Novavax, […]
CARLSBAD, Calif. — Advanced BioMatrix launches CytoSoft® T-25 and T-75 Flasks to completely upend traditional cell culture and cell expansion. CytoSoft® flasks contain a thin layer of biocompatible silicone formulated to a specific stiffness including 0.2, 0.5, 2, 8, 16, 32, and 64 kPa. This range of stiffness mimics the human body – from the […]
Porvair Sciences has launched new kits for rapid extraction of total RNA from a wide range of biological samples. These proprietary kits enable extraction of up to 1000 µg of application-ready pure RNA in as little as 10 minutes. Extraction and purification of RNA is required for numerous downstream molecular biology applications such as RT-PCR, […]
CRISPR offerings to enhance NUVISAN’s drug development service portfolio Dublin, Ireland and Berlin, Germany: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and NUVISAN Innovation Campus Berlin (ICB) GmbH, a fully integrated contract research service provider for drug discovery and early development programs, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
